Nifty
:
18598.65
Sensex
:
62846.38
99.30 (0.54%)
344.69 (0.55%)
Nifty
Sensex
:
:
18598.65
62846.38
99.30 (0.54%)
344.69 (0.55%)

Strides Pharma Science Ltd.

Pharmaceuticals & Drugs - Global

Rating :
47/99

BSE: 532531 | NSE: STAR

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 3,317.72
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 5,922.33
  • 0.41%
  • 1.50

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 28.27%
  • 4.98%
  • 25.51%
  • FII
  • DII
  • Others
  • 18.8%
  • 16.79%
  • 5.65%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -1.70
  • 0.99

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -11.38
  • -17.82

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -27.37
  • 14.42

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 20.35
  • 6.50
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.50
  • 1.69
  • 1.83

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 16.64
  • 16.19
  • 18.78

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Var%
Dec 22
Dec 21
Var%
Sep 22
Sep 21
Var%
Jun 22
Jun 21
Var%
Net Sales
986.37
866.02
13.90%
864.85
794.39
8.87%
897.10
721.47
24.34%
940.07
688.37
36.56%
Expenses
830.81
823.85
0.84%
748.50
792.86
-5.59%
812.93
735.04
10.60%
888.88
743.72
19.52%
EBITDA
155.56
42.16
268.98%
116.34
1.53
7,503.92%
84.17
-13.57
-
51.19
-55.35
-
EBIDTM
15.77%
4.87%
13.45%
0.19%
9.38%
-1.88%
5.45%
-8.04%
Other Income
27.12
86.06
-68.49%
26.20
10.19
157.11%
37.42
22.21
68.48%
22.51
18.65
20.70%
Interest
80.52
49.48
62.73%
58.44
42.25
38.32%
67.64
43.55
55.32%
54.54
41.45
31.58%
Depreciation
60.93
60.68
0.41%
60.22
60.90
-1.12%
61.70
56.56
9.09%
60.40
54.88
10.06%
PBT
33.89
-58.88
-
65.44
-106.86
-
6.77
-151.37
-
-107.01
-224.58
-
Tax
7.09
-131.48
-
4.09
-4.48
-
-38.40
-6.76
-
-28.07
-35.54
-
PAT
26.81
72.60
-63.07%
61.35
-102.38
-
45.17
-144.61
-
-78.94
-189.04
-
PATM
2.72%
8.38%
7.09%
-12.89%
5.04%
-20.04%
-8.40%
-27.46%
EPS
-1.06
3.25
-
-8.86
-13.55
-
2.53
-18.11
-
-15.13
-22.87
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Dec 12
Net Sales
3,688.39
3,070.25
3,315.87
2,981.12
3,108.33
3,344.37
3,826.22
2,862.19
1,195.85
1,340.96
961.76
Net Sales Growth
20.13%
-7.41%
11.23%
-4.09%
-7.06%
-12.59%
33.68%
139.34%
-10.82%
39.43%
 
Cost Of Goods Sold
1,626.89
1,502.32
1,332.79
1,122.48
1,085.20
1,378.84
1,281.17
1,502.29
560.49
714.67
491.82
Gross Profit
2,061.50
1,567.93
1,983.08
1,858.64
2,023.14
1,965.53
2,545.05
1,359.90
635.37
626.30
469.94
GP Margin
55.89%
51.07%
59.81%
62.35%
65.09%
58.77%
66.52%
47.51%
53.13%
46.71%
48.86%
Total Expenditure
3,281.12
3,090.36
2,689.06
2,470.90
2,811.65
3,108.66
3,309.30
2,481.62
967.00
1,117.54
861.18
Power & Fuel Cost
-
71.54
64.58
64.49
54.39
51.33
33.87
77.18
16.02
18.56
12.84
% Of Sales
-
2.33%
1.95%
2.16%
1.75%
1.53%
0.89%
2.70%
1.34%
1.38%
1.34%
Employee Cost
-
646.91
550.15
442.56
329.44
434.05
419.16
357.69
172.06
157.18
120.30
% Of Sales
-
21.07%
16.59%
14.85%
10.60%
12.98%
10.95%
12.50%
14.39%
11.72%
12.51%
Manufacturing Exp.
-
255.52
237.94
210.79
150.98
115.97
137.47
119.23
41.37
35.76
44.43
% Of Sales
-
8.32%
7.18%
7.07%
4.86%
3.47%
3.59%
4.17%
3.46%
2.67%
4.62%
General & Admin Exp.
-
223.67
191.73
191.89
150.10
194.38
172.63
198.71
86.25
66.37
58.16
% Of Sales
-
7.29%
5.78%
6.44%
4.83%
5.81%
4.51%
6.94%
7.21%
4.95%
6.05%
Selling & Distn. Exp.
-
331.30
223.22
137.07
111.22
208.85
161.12
129.57
61.37
66.67
39.94
% Of Sales
-
10.79%
6.73%
4.60%
3.58%
6.24%
4.21%
4.53%
5.13%
4.97%
4.15%
Miscellaneous Exp.
-
59.10
88.65
301.61
930.33
725.25
1,103.88
96.95
29.44
58.33
39.94
% Of Sales
-
1.92%
2.67%
10.12%
29.93%
21.69%
28.85%
3.39%
2.46%
4.35%
9.74%
EBITDA
407.26
-20.11
626.81
510.22
296.68
235.71
516.92
380.57
228.85
223.42
100.58
EBITDA Margin
11.04%
-0.65%
18.90%
17.12%
9.54%
7.05%
13.51%
13.30%
19.14%
16.66%
10.46%
Other Income
113.25
131.99
59.44
66.70
322.90
920.64
398.08
102.37
38.57
60.23
34.20
Interest
261.14
176.74
150.06
155.72
79.29
196.24
183.10
168.17
47.44
108.88
79.45
Depreciation
243.25
233.01
206.29
187.79
171.85
193.93
198.69
131.25
64.03
56.48
30.86
PBT
-0.91
-297.88
329.90
233.42
368.44
766.17
533.20
183.50
155.95
118.30
24.48
Tax
-55.29
-178.26
31.65
17.91
14.49
21.41
51.19
42.45
147.60
40.86
11.15
Tax Rate
6,075.82%
32.91%
8.48%
11.50%
3.71%
2.96%
10.30%
29.87%
99.35%
44.53%
1.54%
PAT
54.39
-460.21
352.32
143.62
370.31
681.31
399.38
113.21
1.57
50.89
712.39
PAT before Minority Interest
64.08
-474.25
341.61
137.82
375.57
701.18
445.58
99.68
0.98
50.89
713.44
Minority Interest
9.69
14.04
10.71
5.80
-5.26
-19.87
-46.20
13.53
0.59
0.00
-1.05
PAT Margin
1.47%
-14.99%
10.63%
4.82%
11.91%
20.37%
10.44%
3.96%
0.13%
3.80%
74.07%
PAT Growth
114.97%
-
145.31%
-61.22%
-45.65%
70.59%
252.78%
7,110.83%
-96.91%
-92.86%
 
EPS
6.02
-50.96
39.02
15.90
41.01
75.45
44.23
12.54
0.17
5.64
78.89

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Dec 12
Shareholder's Funds
2,359.23
2,776.66
2,527.42
2,648.70
2,463.66
2,748.82
2,657.87
1,144.92
1,006.83
2,026.24
Share Capital
89.79
89.68
89.56
89.55
89.50
89.42
89.35
59.62
59.57
58.80
Total Reserves
2,266.99
2,682.26
2,432.13
2,551.59
2,365.10
2,650.55
2,562.75
1,084.50
947.06
1,963.94
Non-Current Liabilities
965.72
1,264.45
813.65
2,342.88
2,067.29
2,048.67
2,760.03
285.79
306.42
900.59
Secured Loans
744.86
873.43
601.79
1,806.45
1,551.09
1,622.87
2,614.88
250.23
274.29
731.15
Unsecured Loans
90.77
9.15
2.12
0.06
0.23
14.84
12.13
17.16
1.24
0.00
Long Term Provisions
64.28
246.50
63.95
52.24
16.55
25.19
14.45
6.02
16.56
57.25
Current Liabilities
3,411.68
2,738.35
2,544.86
2,662.24
1,899.30
3,103.87
1,891.98
1,019.94
707.37
1,797.29
Trade Payables
1,071.52
1,134.20
797.75
888.99
712.07
774.09
775.40
234.41
262.31
463.08
Other Current Liabilities
697.18
421.00
354.49
248.12
129.98
819.08
347.93
502.47
127.27
651.65
Short Term Borrowings
1,496.53
1,023.84
1,228.78
1,339.02
944.39
1,393.96
700.48
203.03
224.56
599.89
Short Term Provisions
146.43
159.31
163.84
186.11
112.86
116.73
68.19
80.03
93.23
82.66
Total Liabilities
6,760.72
6,816.80
5,953.17
7,806.77
6,584.90
8,034.86
7,360.09
2,469.36
2,096.29
4,795.97
Net Block
2,333.45
2,151.13
2,025.85
3,570.13
2,903.00
2,909.03
2,678.68
701.36
554.53
3,016.72
Gross Block
3,231.69
2,841.28
2,534.38
4,049.05
3,229.03
3,186.12
2,825.43
1,080.55
907.33
3,514.29
Accumulated Depreciation
898.24
690.15
508.53
478.92
326.03
277.09
146.75
379.19
352.80
497.57
Non Current Assets
3,398.88
3,999.57
3,581.05
4,758.05
4,101.31
4,243.05
3,845.20
1,039.91
787.65
3,383.87
Capital Work in Progress
291.08
447.37
412.95
453.03
620.29
780.18
814.88
171.17
99.47
241.44
Non Current Investment
540.34
666.23
503.24
494.34
350.08
315.66
127.19
68.76
41.80
0.00
Long Term Loans & Adv.
208.50
185.80
210.82
223.69
197.22
222.56
201.83
96.72
90.40
118.75
Other Non Current Assets
12.34
549.04
428.19
16.86
30.72
15.62
22.62
1.91
1.45
6.96
Current Assets
3,361.83
2,817.23
2,372.11
3,048.72
2,483.59
3,791.82
3,514.89
1,429.44
1,308.63
1,410.94
Current Investments
0.00
99.41
118.97
284.75
311.48
1,279.54
1,213.76
561.29
401.24
0.06
Inventories
1,173.80
1,200.70
782.54
874.16
552.02
732.80
613.14
207.68
175.99
442.33
Sundry Debtors
1,207.30
1,110.59
931.69
987.18
882.18
995.91
1,032.97
389.96
364.00
483.23
Cash & Bank
187.35
179.76
237.10
516.65
303.33
329.48
311.59
146.88
231.15
165.74
Other Current Assets
793.39
98.22
83.57
136.87
434.59
454.09
343.44
123.64
136.26
319.58
Short Term Loans & Adv.
145.49
128.54
218.24
249.11
295.75
244.39
97.54
54.46
79.06
44.38
Net Current Assets
-49.84
78.89
-172.75
386.48
584.29
687.95
1,622.91
409.50
601.26
-386.35
Total Assets
6,760.71
6,816.80
5,953.16
7,806.77
6,584.90
8,034.87
7,360.09
2,469.35
2,096.28
4,795.98

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Dec 12
Cash From Operating Activity
-257.81
481.44
204.79
60.05
187.07
288.14
73.25
83.40
-271.68
134.26
PBT
-652.51
289.38
48.51
344.37
705.80
497.14
146.44
992.01
2,889.87
949.49
Adjustment
582.27
363.31
527.49
94.59
-274.51
190.92
345.56
-756.73
-2,775.01
-415.93
Changes in Working Capital
-189.90
-328.05
-326.23
-323.14
-190.66
-341.30
-341.71
-95.91
-260.68
-310.56
Cash after chg. in Working capital
-260.14
324.64
249.76
115.82
240.63
346.76
150.29
139.37
-145.81
223.00
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
2.33
156.80
-44.98
-55.76
-53.56
-58.62
-77.04
-55.97
-125.87
-88.75
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-118.73
-520.82
1,306.16
-148.49
582.59
-686.69
-2,224.83
51.87
4,077.09
806.54
Net Fixed Assets
-61.59
-86.75
-167.06
-48.49
677.20
-236.66
-535.93
-66.57
-119.10
-38.27
Net Investments
62.72
-219.57
-17.15
-383.09
747.64
-143.27
-1,478.58
78.09
248.81
-508.54
Others
-119.86
-214.50
1,490.37
283.09
-842.25
-306.76
-210.32
40.35
3,947.38
1,353.35
Cash from Financing Activity
421.32
-15.80
-1,709.45
194.27
-1,015.69
338.21
2,943.94
-421.25
-3,318.53
-990.03
Net Cash Inflow / Outflow
44.77
-55.18
-198.50
105.83
-246.03
-60.33
792.35
-285.98
486.88
-49.23
Opening Cash & Equivalents
125.83
182.23
365.89
256.16
515.08
1,110.74
298.91
586.00
132.02
211.93
Closing Cash & Equivalent
170.73
125.83
182.23
365.89
256.16
515.08
1,110.74
298.42
586.00
132.02

Financial Ratios

Consolidated /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Dec 12
Book Value (Rs.)
262.48
309.09
281.55
294.94
274.26
306.41
296.83
191.91
168.99
343.78
ROA
-6.99%
5.35%
2.00%
5.22%
9.59%
5.79%
2.03%
0.04%
1.48%
14.07%
ROE
-18.49%
12.91%
5.34%
14.74%
27.00%
16.53%
5.25%
0.09%
3.36%
42.16%
ROCE
-9.49%
11.17%
6.01%
8.65%
16.07%
10.75%
7.54%
10.92%
7.76%
21.08%
Fixed Asset Turnover
1.75
2.04
1.50
1.17
1.04
1.27
1.47
1.21
0.61
0.27
Receivable days
79.41
68.09
70.88
79.95
102.49
96.77
90.73
114.71
114.80
193.43
Inventory Days
81.35
66.13
61.20
61.00
70.11
64.20
52.34
58.37
83.78
174.61
Payable days
267.95
264.54
138.58
146.59
116.23
117.33
75.51
76.81
112.69
253.28
Cash Conversion Cycle
-107.20
-130.32
-6.50
-5.64
56.37
43.64
67.55
96.27
85.89
114.76
Total Debt/Equity
1.18
0.76
0.78
1.22
1.03
1.35
1.34
0.78
0.54
0.79
Interest Cover
-2.69
3.49
2.00
5.92
4.68
3.71
1.85
4.13
1.84
10.12

Annual Reports:

FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014
FY 2013
FY 2012

News Update:


  • Strides Pharma Science gets EIR from USFDA for Puducherry manufacturing facility
    19th May 2023, 09:14 AM

    The USFDA has classified the facility from Official Action Indicated to Voluntary Action Indicated

    Read More
  • USFDA issues EIR to Strides Pharma Science’s Bangalore facility
    24th Feb 2023, 11:38 AM

    The Company’s flagship facility was inspected by the USFDA between December 5 and 9, 2022

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.